Patents by Inventor John Fenyu JIN

John Fenyu JIN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PYRIMIDOHETEROCYCLIC COMPOUNDS AND APPLICATION THEREOF
    Publication number: 20240116934
    Abstract: A class of pyrimidoheterocyclic compounds, and specifically disclosed is a compound represented by formula (III) or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: September 22, 2023
    Publication date: April 11, 2024
    Inventors: Yang ZHANG, Wentao WU, Jing ZHANG, Jikui SUN, Yangyang XU, Zhijian CHEN, John Fenyu JIN, Shuhui CHEN
  • PYRIMIDOHETEROCYCLIC COMPOUNDS AND APPLICATION THEREOF
    Publication number: 20230151004
    Abstract: A class of pyrimidoheterocyclic compounds, and specifically disclosed is a compound represented by formula (III) or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: March 11, 2021
    Publication date: May 18, 2023
    Inventors: Yang ZHANG, Wentao WU, Jing ZHANG, Jikui SUN, Yangyang XU, Zhijian CHEN, John Fenyu JIN, Shuhui CHEN
  • Inhibitor of metadherin expression
    Publication number: 20230067620
    Abstract: The present invention refers to an inhibitor consisting of an oligonucleotide comprising 12 to 25 nucleotides, wherein at least one of the nucleotides is modified, and the oligonucleotide hybridizes with a nucleic acid sequence of MTDH of SEQ ID NO.1 (human mRNA), SEQ ID NO.2 (human pre-mRNA), SEQ ID NO.223 (mouse mRNA) and/or SEQ ID NO.224 (mouse pre-mRNA), wherein the oligonucleotide inhibits at least 50% of the MTDH expression. The invention is further directed to a pharmaceutical composition comprising such oligonucleotide.
    Type: Application
    Filed: September 14, 2020
    Publication date: March 2, 2023
    Inventors: Frank JASCHINSKI, Richard KLAR, Sven MICHEL, John Fenyu JIN